David Wilkie

David Wilkie, PhD, is a seasoned professional in clinical research and management with extensive experience across various roles in the industry. Currently serving as a Senior Clinical Study Manager at Allergy Therapeutics since November 2022, David leads first-in-human studies while overseeing multiple sites in the US. Previous roles include Global Clinical Trial Manager at DOCS, where responsibilities encompassed managing non-Amgen sponsored clinical research, as well as Senior Country Coordinator at Marken, focusing on international multi-site study support. David's academic credentials include a Doctor of Philosophy in Clinical Medicine from Imperial College London, complementing a strong foundation in journalism acquired through degrees from the University of Sunderland and Newcastle College.